Clinical Trial Update: FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

View source ↗

Summary

This update reports on the FORCE trial evaluating FibroScan, a non-invasive liver fibrosis assessment tool, in pediatric cholestatic liver disease. The study in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alagille Syndrome
• Alpha-1 Antitrypsin Deficiency
• Biliary Atresia
• Cholestasis
• Liver Fibrosis
• Portal Hypertension

Snippet

Sponsor: Arbor Research Collaborative for Health | Conditions: Biliary Atresia, Alagille Syndrome | Status: COMPLETED